These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin. Hjorth CF; Hubálek F; Andersson J; Poulsen C; Otzen D; Naver H Pharm Res; 2015 Jun; 32(6):2072-85. PubMed ID: 25583030 [TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro stability for insulin aspart and insulin glulisine during simulated use in insulin pumps. Senstius J; Poulsen C; Hvass A Diabetes Technol Ther; 2007 Dec; 9(6):517-21. PubMed ID: 18034606 [TBL] [Abstract][Full Text] [Related]
11. Identification of N-Terminally Truncated Derivatives of Insulin Analogs Formed in Pharmaceutical Formulations. Zielińska J; Stadnik J; Bierczyńska-Krzysik A; Stadnik D Pharm Res; 2018 May; 35(7):143. PubMed ID: 29770892 [TBL] [Abstract][Full Text] [Related]
13. Optimising insulin aspart practices in a neonatal intensive care unit: a clinical and pharmaco-technical study. Préta LH; Genay S; Malat C; Carta N; Boukhris MR; Verspieren J; Odou P; Storme L; Décaudin B Eur J Pediatr; 2021 Sep; 180(9):2985-2992. PubMed ID: 33866404 [TBL] [Abstract][Full Text] [Related]
14. A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus. Heise T; Hövelmann U; Zijlstra E; Stender-Petersen K; Jacobsen JB; Haahr H Drugs Aging; 2017 Jan; 34(1):29-38. PubMed ID: 27873152 [TBL] [Abstract][Full Text] [Related]
15. A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study. Ma Z; Parkner T; Frystyk J; Laursen T; Lauritzen T; Christiansen JS Diabetes Technol Ther; 2012 Jul; 14(7):589-95. PubMed ID: 22519735 [TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Bode BW Endocr Pract; 2011; 17(2):271-80. PubMed ID: 21134878 [TBL] [Abstract][Full Text] [Related]
17. Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes. Raja-Khan N; Warehime SS; Gabbay RA Vasc Health Risk Manag; 2007; 3(6):919-35. PubMed ID: 18200811 [TBL] [Abstract][Full Text] [Related]
18. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Mudaliar SR; Lindberg FA; Joyce M; Beerdsen P; Strange P; Lin A; Henry RR Diabetes Care; 1999 Sep; 22(9):1501-6. PubMed ID: 10480516 [TBL] [Abstract][Full Text] [Related]